Document is current
Any future updates will be listed below
-
Authors
Chou, Tsung-Han http://orcid.org/0000-0001-6154-6283
Epstein, Max
Fritzemeier, Russell G.
Akins, Nicholas S.
Paladugu, Srinu
Ullman, Elijah Z.
Liotta, Dennis C.
Traynelis, Stephen F. http://orcid.org/0000-0002-3750-9615
Furukawa, Hiro http://orcid.org/0000-0001-8296-8426
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 20 June 2024
First Online: 31 July 2024
Competing interests
: S.F.T. is a member of the medical advisory boards for the CureGRIN Foundation and the GRIN2B Foundation; a member of the scientific advisory boards for Sage Therapeutics, Eumentis Therapeutics, and Neurocrine; a Senior Advisor for GRIN Therapeutics; a co-founder of NeurOp, Inc and AgriThera, Inc.; and is on the Board of Directors for NeurOp Inc. D.C.L. is on the Board of Directors for NeurOp Inc. Several authors (R.G.F., N.S.A., S.P., S.F.T., D.C.L.) are co-inventors on Emory-owned IP involving NMDA receptor modulators. The other authors declare no competing interests.
